Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hyperkalemia associated with ketorolac.

F A Rotenberg1, V S Giannini

  • 1Department of Anesthesiology, Rhode Island Hospital, Providence 02903.

The Annals of Pharmacotherapy
|June 1, 1992
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Stroke during coronary artery bypass grafting using hypothermic versus normothermic perfusion.

The Annals of thoracic surgery·1995
Same author

Warm body, cold heart: myocardial revascularization in 2383 consecutive patients.

The Journal of cardiovascular surgery·1993
Same author

Warm body, cold heart surgery. Clinical experience in 2817 patients.

European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery·1993
Same author

Effects of clonidine on vulnerability to fibrillation in the normal and ischemic canine ventricle.

European journal of pharmacology·1978
Same journal

Efficacy and Safety of Oral PCSK9 Inhibitors in Adults With Hypercholesterolemia: An Updated Systematic Review and Meta-Analysis of RCTs.

The Annals of pharmacotherapy·2026
Same journal

RSVpreF: A Vaccine for the Respiratory Syncytial Virus.

The Annals of pharmacotherapy·2026
Same journal

Modified vs Full Lead-in Dose Apixaban and Rivaroxaban for Treatment of Acute Venous Thromboembolism.

The Annals of pharmacotherapy·2026
Same journal

A Comparison of Phenobarbital Dosing Strategies for the Treatment of Alcohol Withdrawal Syndrome.

The Annals of pharmacotherapy·2026
Same journal

Four-Year Evaluation of a Pharmacists-Providers Collaborative Iron Deficiency Clinic in Heart Failure Care.

The Annals of pharmacotherapy·2026
Same journal

Efficacy and Safety of Pioglitazone Added to Metformin and SGLT2 Inhibitors in Type 2 Diabetes: An Updated Systematic Review and Meta-analysis.

The Annals of pharmacotherapy·2026
See all related articles

This case study reports hyperkalemia after intramuscular ketorolac, a nonsteroidal anti-inflammatory drug (NSAID). Prostaglandin synthesis suppression is the suspected cause, highlighting the need for careful patient monitoring.

Area of Science:

  • Pharmacology
  • Nephrology
  • Clinical Medicine

Background:

  • Nonsteroidal anti-inflammatory drugs (NSAIDs) are commonly used for pain management.
  • Hyperkalemia is a known potential adverse effect of some NSAIDs.
  • Ketorolac is a potent NSAID often administered intramuscularly for moderate to severe pain.

Observation:

  • A 59-year-old male patient developed hyperkalemia after receiving a 30 mg intramuscular injection of ketorolac for postoperative incisional pain.
  • Other potential causes of hyperkalemia, including concurrent medications and perioperative events, were systematically excluded.

Findings:

  • This case represents the apparent first report of hyperkalemia specifically linked to intramuscular ketorolac administration.
  • The proposed mechanism involves NSAID-induced suppression of prostaglandin synthesis, which can impair potassium excretion.

Related Experiment Videos

  • Similar hyperkalemic effects have been documented with other NSAIDs.
  • Implications:

    • Parenteral ketorolac may precipitate hyperkalemia, necessitating vigilant monitoring of serum electrolytes in patients receiving this medication.
    • Clinicians should consider ketorolac as a potential cause of hyperkalemia in the postoperative setting.
    • Further research may be warranted to fully elucidate the risk and incidence of ketorolac-induced hyperkalemia.